Alison M. Bratt

458 total citations
16 papers, 375 citations indexed

About

Alison M. Bratt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Alison M. Bratt has authored 16 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Alison M. Bratt's work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Alison M. Bratt is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Alison M. Bratt collaborates with scholars based in United Kingdom, United States and France. Alison M. Bratt's co-authors include Clyde W. Hodge, Stephen P. Kelley, Michelle Nannini, Joyce Besheer, Jason P. Schroeder, Guy Mittleman, Robert J. Naylor, B. Costall, A.M. Domeney and M.E. Kelly and has published in prestigious journals such as Neuropsychopharmacology, Experimental Brain Research and Psychopharmacology.

In The Last Decade

Alison M. Bratt

16 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison M. Bratt United Kingdom 10 240 123 105 55 50 16 375
M. Decobert France 9 142 0.6× 94 0.8× 90 0.9× 58 1.1× 39 0.8× 11 314
Jason Katner United States 11 290 1.2× 154 1.3× 131 1.2× 60 1.1× 45 0.9× 14 484
JoséN. Nobrega Canada 11 270 1.1× 137 1.1× 110 1.0× 42 0.8× 54 1.1× 22 462
Dominique Duterte‐Boucher France 14 336 1.4× 151 1.2× 71 0.7× 53 1.0× 33 0.7× 24 416
Nather Madjid Sweden 12 300 1.3× 189 1.5× 104 1.0× 39 0.7× 30 0.6× 17 410
Anna K. Läck United States 9 376 1.6× 146 1.2× 169 1.6× 80 1.5× 25 0.5× 9 486
Gh. Perrault France 8 293 1.2× 191 1.6× 59 0.6× 53 1.0× 31 0.6× 12 408
Harold L. Haun United States 10 276 1.1× 117 1.0× 109 1.0× 65 1.2× 33 0.7× 19 397
Valérie Fauchey France 6 253 1.1× 135 1.1× 73 0.7× 33 0.6× 19 0.4× 6 369
Sophie Tambour Belgium 11 370 1.5× 147 1.2× 92 0.9× 56 1.0× 27 0.5× 14 542

Countries citing papers authored by Alison M. Bratt

Since Specialization
Citations

This map shows the geographic impact of Alison M. Bratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Bratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Bratt more than expected).

Fields of papers citing papers by Alison M. Bratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison M. Bratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Bratt. The network helps show where Alison M. Bratt may publish in the future.

Co-authorship network of co-authors of Alison M. Bratt

This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Bratt. A scholar is included among the top collaborators of Alison M. Bratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Bratt. Alison M. Bratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Bratt, Alison M., et al.. (2016). Hypothalamic-pituitary-adrenal axis function in Fragile X Syndrome and its relationship to behaviour: A systematic review. Physiology & Behavior. 167. 341–353. 15 indexed citations
3.
Hodge, Clyde W., et al.. (2004). 5-HT3A Receptor Subunit is Required for 5-HT3 Antagonist-Induced Reductions in Alcohol Drinking. Neuropsychopharmacology. 29(10). 1807–1813. 41 indexed citations
4.
Kelley, Stephen P., Alison M. Bratt, & Clyde W. Hodge. (2003). Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. European Journal of Pharmacology. 461(1). 19–25. 84 indexed citations
5.
Bratt, Alison M., et al.. (2003). Enhancing Quality in the M.Pharm Degree Programme: Optimisation of the Personal Tutor System. Pharmacy Education. 3(2). 103–108. 8 indexed citations
6.
7.
Kelley, Stephen P., Michelle Nannini, Alison M. Bratt, & Clyde W. Hodge. (2001). Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration. Peptides. 22(3). 515–522. 81 indexed citations
8.
9.
Hodge, Clyde W., Alison M. Bratt, Rosana Camarini, et al.. (2001). The discriminative stimulus properties of self-administered ethanol are mediated by GABA A and NMDA receptors in rats. Psychopharmacology. 154(1). 13–22. 30 indexed citations
10.
Mittleman, Guy, et al.. (1998). Heterogeneity of the hippocampus: effects of subfield lesions on locomotion elicited by dopaminergic agonists. Behavioural Brain Research. 92(1). 31–45. 21 indexed citations
11.
Bratt, Alison M., M.E. Kelly, A.M. Domeney, Robert J. Naylor, & B. Costall. (1996). Acute and chronic arecoline: Effects on a scopolamine-induced deficit in complex maze learning. Pharmacology Biochemistry and Behavior. 53(3). 713–721. 9 indexed citations
12.
Bratt, Alison M., J.C. Cassel, B. Neufang, et al.. (1995). Behavioural and neurochemical effects of superior cervical ganglionectomy in rats with septo-hippocampal lesions. Experimental Brain Research. 102(3). 429–44. 9 indexed citations
13.
Bratt, Alison M., Kaye Stacey, R. Chase, & Guy Mittleman. (1995). P-3-24 Modelling attentional deficits in schizophrenia: Hippocampal subfield lesions and performance of a 5-choice reaction time task in the rat. European Neuropsychopharmacology. 5(3). 324–325. 1 indexed citations
14.
Bratt, Alison M., M.E. Kelly, A.M. Domeney, Robert J. Naylor, & B. Costall. (1994). Ondansetron fails to attenuate a scopolamineinduced deficit in a Stone maze task. Neuroreport. 5(15). 1921–1924. 15 indexed citations
15.
Greene, Paul L., Jean‐Christophe Cassel, Christian Kelche, et al.. (1994). Differential behavioral effects of supracallosal and infracallosal lesions of the septohippocampal pathways: No ameliorative effects of oxotremorine or pilocarpine on radial-maze performance. Behavioral and Neural Biology. 62(1). 4–14. 6 indexed citations
16.
Bratt, Alison M., M.E. Kelly, A.M. Domeney, Robert J. Naylor, & B. Costall. (1994). Aged Stone mazeimpaired rats exhibit reduced striatal muscarinic receptor densities. Neuroreport. 5(18). 2678–2682. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Decobert Breakdown of academic impact, for papers by Jason Katner Breakdown of academic impact, for papers by JoséN. Nobrega Breakdown of academic impact, for papers by Dominique Duterte‐Boucher Breakdown of academic impact, for papers by Nather Madjid Breakdown of academic impact, for papers by Anna K. Läck Breakdown of academic impact, for papers by Gh. Perrault Breakdown of academic impact, for papers by Harold L. Haun Breakdown of academic impact, for papers by Valérie Fauchey Breakdown of academic impact, for papers by Sophie Tambour
Rankless by CCL
2026